Blood-biomaterial interface: where medicine and biology meet physical sciences and engineering
Madren Conference Center, Clemson, SC, USA
Limited understanding of the mechanisms underlying adverse reactions to foreign materials upon contact with blood continues to hinder the development of new clinical devices and advanced treatment options for cardiovascular disorders. Addressing the problem will require the efforts of practitioners from diverse fields – clinicians and engineers, biologists and physicists. The goal of this – second – meeting, is to bring them together. Platelets will form the central theme of this meeting in view of their key role in defining blood response to biomaterials.
Post conference publication: Opinion paper “BloodSurf 2017: News from the blood-biomaterial frontier”, Irini Sotiri, Matthew Robichaud, David Lee, Steffen Braune, Maud Gorbet, Buddy D. Ratnera, John L. Brashe, Robert A. Latour, and Ilya Reviakine, Acta Biomaterialia, Volume 87, 15 March 2019, Pages 55-60; https://doi.org/10.1016/j.actbio.2019.01.032